{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:53:28Z","timestamp":1747169608238,"version":"3.40.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.prp.2018.10.020","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T18:15:39Z","timestamp":1540318539000},"page":"222-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antiphospholipid antibodies associated with nodal marginal zone lymphoma and its progression to diffuse large B-cell lymphoma\u2014A case report"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7848-6600","authenticated-orcid":false,"given":"Andrej","family":"Belan\u010di\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luka","family":"Vrani\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"\u0160eveljevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1800-3552","authenticated-orcid":false,"given":"Ita","family":"Had\u017eisejdi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antica Duleti\u0107","family":"Na\u010dinovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nives","family":"Jonji\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2018.10.020_bib0005","first-page":"564","article-title":"The prevalence and clinical significance of Anticardiolipin Antibody in acute myeloblastic leukemia","volume":"12","author":"Ramzi","year":"2010","journal-title":"IRCMJ"},{"key":"10.1016\/j.prp.2018.10.020_bib0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF03165086","article-title":"Recent advances in the diagnosis of antiphospholipid syndrome","volume":"76","author":"Hyun-Sook","year":"2002","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.prp.2018.10.020_bib0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.semarthrit.2005.07.003","article-title":"Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients","volume":"35","author":"Gomez-Puerta","year":"2006","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.prp.2018.10.020_bib0020","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","article-title":"Management of antiphospholipid antibody syndrome: a systematic review","volume":"95","author":"Lim","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.prp.2018.10.020_bib0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12016-007-0003-1","article-title":"Antiphospholipid syndrome and cancer","volume":"32","author":"Reinstein","year":"2007","journal-title":"Clin. Rev. Allerg. Immunol."},{"key":"10.1016\/j.prp.2018.10.020_bib0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1163\/156855900300109549","article-title":"Catastrophic antiphospholipid syndrome in cancer","volume":"30","author":"Soltesz","year":"2000","journal-title":"Haematologia (Budap)"},{"year":"2017","series-title":"WHO Classification of Tumours of Haematopoetic and Lymphoid Tissue","author":"Swerdlow","key":"10.1016\/j.prp.2018.10.020_bib0035"},{"key":"10.1016\/j.prp.2018.10.020_bib0040","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.1999.17.8.2486","article-title":"Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin'slymphoma classification project","volume":"17","author":"Nathwani","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2018.10.020_bib0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1349-7006.2006.00345.x","article-title":"Clinical implication of nodal marginal zone B-cell lymphoma among Japanese: study of 65 cases","volume":"98","author":"Kojima","year":"2007","journal-title":"9 Cancer Sci."},{"key":"10.1016\/j.prp.2018.10.020_bib0050","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","article-title":"Recognizing nodal marginal zone lymphoma: recent advances and pitfalls","volume":"98","author":"van den Brand","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2018.10.020_bib0055","first-page":"433","article-title":"Diffuse large cell lymphoma presenting as a sacral mass and lupus anticoagulant","volume":"84","author":"Ediriwickrema","year":"2011","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.prp.2018.10.020_bib0060","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2018.10.020_bib0065","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/jcp.43.11.888","article-title":"Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction","volume":"43","author":"Wan","year":"1990","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2018.10.020_bib0070","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0248-8663(01)00348-4","article-title":"Non-simultaneous malignant lymphoma and antiphospholipid syndrome: 4 cases","volume":"22","author":"Liozon","year":"2001","journal-title":"Rev. Med. Intern."},{"key":"10.1016\/j.prp.2018.10.020_bib0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1096-8652(199707)55:3<167::AID-AJH12>3.0.CO;2-A","article-title":"Anti-phospholipid-antibody syndrome associated with peripheral T-cell lymphoma","volume":"55","author":"Onida","year":"1997","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.prp.2018.10.020_bib0080","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.autrev.2009.04.001","article-title":"Antiphospholipid antibodies and malignancies","volume":"9","author":"Tincani","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.prp.2018.10.020_bib0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.thj.6200377","article-title":"Antiphospholipid antibodies in lymphoma: prevalence and clinical significance","volume":"5","author":"Pusterla","year":"2004","journal-title":"Hematol. J."},{"key":"10.1016\/j.prp.2018.10.020_bib0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1600-0609.2002.01526.x","article-title":"Prevalence and clinical significance of anticardiolipin and anti-Beta2-gylcoproetien-I antibodies in patients with non-Hodgkin\u2019s lymphoma","volume":"68","author":"Genvresse","year":"2002","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.prp.2018.10.020_bib0095","first-page":"475","article-title":"Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation","volume":"7","author":"Conlan","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.prp.2018.10.020_bib0100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1055\/s-0038-1649628","article-title":"Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin\u2019s lymphoma","volume":"70","author":"Stasi","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.prp.2018.10.020_bib0105","doi-asserted-by":"crossref","unstructured":"Koumati E, Palassopoulou M, Matsouka P, Polyzos A, Dalekos GN, Zachou K, Multiple autoimmune propensity and B-non-Hodgkin lymphoma: cause or effect?, Autoimmune Dis. https:\/\/doi.org\/10.4061\/2011\/841325.","DOI":"10.4061\/2011\/841325"},{"key":"10.1016\/j.prp.2018.10.020_bib0110","first-page":"26","article-title":"Mycosis fungoides masquerading as cutaneous lupus erythematous and associated with antiphospholipid syndrome","volume":"33","author":"Veysey","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.prp.2018.10.020_bib0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5414\/CPP50074","article-title":"Angioimmunoblastic T-cell lymphoma, combined with antiphospholipid syndrome and autoimmune thrombocytopenia (Case report)","volume":"50","author":"Schultheus","year":"2012","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.prp.2018.10.020_bib0120","first-page":"1197","article-title":"Lymphoma-induced antiphospholipid syndrome as a cause of splenic infarction","volume":"137","author":"Lorenzen","year":"2012","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.prp.2018.10.020_bib0125","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.thromres.2014.08.021","article-title":"Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma","volume":"134","author":"Gebhart","year":"2014","journal-title":"Thromb. Res. Suppl."},{"key":"10.1016\/j.prp.2018.10.020_bib0130","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/rheumatology\/41.5.550","article-title":"Value of autoantibodies to beta2-glycoprotein 1 in the diagnosis of antiphospholipid syndrome","volume":"41","author":"Audrain","year":"2002","journal-title":"Rheumatology."},{"key":"10.1016\/j.prp.2018.10.020_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13317-013-0056-5","article-title":"Treatment of the antiphospholipid syndrome","volume":"5","author":"Galli","year":"2014","journal-title":"Autoimmun Highlights"},{"key":"10.1016\/j.prp.2018.10.020_bib0140","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1538-7836.2009.03588.x","article-title":"The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study","volume":"7","author":"de Laat","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.prp.2018.10.020_bib0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.prp.2018.10.020_bib0150","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/keh308","article-title":"Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren\u2019s syndrome","volume":"43","author":"Harner","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.prp.2018.10.020_bib0155","first-page":"57","article-title":"Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin\u2019s lymphoma","volume":"86","author":"Sciarra","year":"1995","journal-title":"Recent Prog. Med."},{"key":"10.1016\/j.prp.2018.10.020_bib0160","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3892\/ol.2013.1585","article-title":"Occult pulmonary mucosa-associated lymphoid tissue lymphoma as catastrophic antiphospholipid antibody syndrome","volume":"6","author":"Regunath","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2018.10.020_bib0165","first-page":"104","article-title":"Remission of severe antiphospholipid syndrome associated with non-Hodgkin\u2019s lymphoma after combined treatment with rituximab and chemotherapy","volume":"90","author":"Veneri","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2018.10.020_bib0170","first-page":"179","article-title":"Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin\u2019s lymphoma","volume":"28","author":"Simon","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.prp.2018.10.020_bib0175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-0609.2005.00620.x","article-title":"Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin\u2019s lymphoma","volume":"76","author":"Bairey","year":"2006","journal-title":"Eur. J. Haematol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818306563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818306563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T14:07:35Z","timestamp":1662300455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033818306563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0344033818306563"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2018.10.020","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid antibodies associated with nodal marginal zone lymphoma and its progression to diffuse large B-cell lymphoma\u2014A case report","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2018.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}